BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:RNA-targeting small molecules are rapidly emerging as a powerf
 ul therapeutic reality. From modulating splicing to directly binding RNAs
 \, these molecules offer a revolutionary approach to treating previously 
 undruggable diseases across neurodegenerative\, cancer and rare disorders
 . In 2025 alone\, the field has seen major collaborations\, including Way
 finder Biosciences with Daiichi Sankyo\, Ono Pharmaceutical with Reborna 
 Biosciences\, and xFOREST with Astellas Pharma-signaling growing momentum
  and industry confidence.\n\nNow in its 8th year\, the RNA-Targeted Drug 
 Discovery and Development Summit returns as the only dedicated industry f
 orum addressing the unique challenges of RNA-targeted drug development ac
 ross splice modulators\, covalent drugs\, proximity inducers and direct R
 NA binders.\n\nJoin 25+ world-class speakers from leaders like PTC Therap
 eutics\, ReviR Therapeutics\, Remix Therapeutics\, Rgenta Therapeutics\, 
 Arrakis Therapeutics and more this December to gain the connections\, too
 ls and scientific firepower needed to bring your RNA-targeted therapeutic
 s to clinic and beyond.\n\nURLs:Tickets:&nbsp\;https://go.evvnt.com/31810
 66-2?pid=185Brochure:&nbsp\;https://go.evvnt.com/3181066-3?pid=185\n\nPri
 ces:Drug developer Pricing - Conference + 2 Workshops: USD 4197.00\,Drug 
 developer Pricing - Conference + 1 Workshop: USD 3598.00\,Drug developer 
 Pricing - Conference Only: USD 2999.00\,Academic Pricing - Conference + 2
  Workshops: USD 3597.00\,Academic Pricing - Conference + 1 Workshop: USD 
 3098.00\,Academic Pricing - Conference Only: USD 2599.00\,Service Provide
 r Pricing - Conference Only: USD 3699.00\,Service Provider Pricing - Conf
 erence + 2 Workshops: USD 5097.00\,Service Provider Pricing - Conference 
 + 1 Workshop: USD 4398.00\n\nSpeakers:&nbsp\;Adam Buckle\, Chief Scientif
 ic Officer\, Arrayjet\, Amanda Hargrove\, Professor of Chemistry\, Univer
 sity of Toronto\, Atsushi Shiomi\, Director of Innovation Research Partne
 ring\, NS Pharma\, Inc.\, Balajee Somalinga\, Director of RNA Biology\, C
 HDI Foundation\, Brittany Morgan\, Assistant Professor\, University of No
 tre Dame\, Christopher Trotta\, Senior Vice President of Discovery Biolog
 y\, &nbsp\;PTC Therapeutics\, David Sparkman-Yager\, Chief Technology Off
 icer\, Wayfinder Biosciences\, Dominic Reynolds\, CSO\, Remix Therapeutic
 s\, Elena Diez\, Cecilia Senior Director of External Innovation\, DPDS\, 
 Johnson and Johnson\, Ella Czarina Morishita\, Chief Scientific Officer\,
  Veritas In Silico Inc.\, Jeffrey Kieft\, Executive Director\, New York S
 tructural Biology Center\, Jennifer Petter\, Chief Scientific Officer\, A
 rrakis Therapeutics Inc.\, Jerry McMahon\, President and Chief Executive 
 Officer\, STORM Therapeutics Ltd.\, Jimin Hwang\, Researcher\, &nbsp\;Pyl
 e Lab at Yale University\, Karen Wu\, Chief Executive Officer and Co-Foun
 der\, &nbsp\;Lucerna\, Inc.\, Kevin Weeks\, Distinguished Professor\, Dep
 artment of Chemistry\, &nbsp\;UNC at Chapel Hill\, Ku-Lung (Ken) Hsu\, As
 sociate Professor\, The University of Texas at Austin\, Matt Woll\, Senio
 r Vice President of Chemistry\, PTC Therapeutics\, Nikolai Naryshkin\, Ch
 ief Scientific Officer\, Ribonaut Therapeutics\, Paige Diamond\, Senior I
 nvestigator\, Interdict Bio\, Peng Yue\, Co-Founder and Chief Executive O
 fficer\, ReviR Therapeutics\, Perla Breccia\, Senior Director of Chemistr
 y\, Astex Pharmaceuticals\, Shunichi Kashida\, Co-Founder\, Representativ
 e Director\, President and CEO\, xFOREST Therapeutics Co. Ltd.\, Stephan 
 Eismann\, Head of Machine Learning\, Atomic AI\, Thomas Wynn\, Director o
 f Medicinal Chemistry\, Rgenta Therapeutics Inc.\, Yaqiang Wang\, Assista
 nt Professor\, Medical College of Wisconsin\n\nCategory:&nbsp\;Conference
 s | Science\, Health and Medicine | Pharmaceuticals\n\nDate and Time:&nbs
 p\;2nd December 2025 at 7:00 am to 4th December 2025 at 6:00 pm\n\nVenue 
 details:&nbsp\;The Westin Boston Seaport District\, 425 Summer Street\, B
 oston\, Massachusetts\, 02210\, United States\n
DTEND:20251204T180000
DTSTAMP:20260512T214304Z
DTSTART:20251202T070000
LOCATION:The Westin Boston Seaport District\, 425\, Summer Street\, Boston
 \, Massachusetts\, 02210\,
SEQUENCE:0
SUMMARY:RNA-targeting small molecules are rapidly emerging as a powerful t
 herapeutic reality. From modulating splicing to directly binding RNAs\, t
 hese mole...
UID:b84333df-965e-426e-a3af-b131e5954f86
END:VEVENT
END:VCALENDAR